R Sanders Williams - Net Worth and Insider Trading

R Sanders Williams Net Worth

The estimated net worth of R Sanders Williams is at least $3 Million dollars as of 2024-04-12. R Sanders Williams is the Director of Amgen Inc and owns about 5,301 shares of Amgen Inc (AMGN) stock worth over $1 Million. R Sanders Williams is the Director of Laboratory Corp of America Holdings and owns about 6,431 shares of Laboratory Corp of America Holdings (LH) stock worth over $1 Million. R Sanders Williams is also the Director of Bristol-Myers Squibb Co and owns about 500 shares of Bristol-Myers Squibb Co (BMY) stock worth over $24,430. Details can be seen in R Sanders Williams's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R Sanders Williams has not made any transactions after 2022-08-22 and currently still holds the listed stock(s).

Transaction Summary of R Sanders Williams

To

R Sanders Williams Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, R Sanders Williams owns 4 companies in total, including Amgen Inc () , Laboratory Corp of America Holdings () , and Bristol-Myers Squibb Co () among others .

Click here to see the complete history of R Sanders Williams’s form 4 insider trades.

Insider Ownership Summary of R Sanders Williams

Ticker Comapny Transaction Date Type of Owner
Amgen Inc 2022-08-22 director
Laboratory Corp of America Holdings 2022-03-25 director
Bristol-Myers Squibb Co 2006-09-11 director
Tenaya Therapeutics Inc 2021-07-29 director

R Sanders Williams Latest Holdings Summary

R Sanders Williams currently owns a total of 3 stocks. Among these stocks, R Sanders Williams owns 5,301 shares of Amgen Inc (AMGN) as of August 22, 2022, with a value of $1 Million and a weighting of 51.37%. R Sanders Williams owns 6,431 shares of Laboratory Corp of America Holdings (LH) as of March 25, 2022, with a value of $1 Million and a weighting of 47.75%. R Sanders Williams also owns 500 shares of Bristol-Myers Squibb Co (BMY) as of September 11, 2006, with a value of $24,430 and a weighting of 0.89%.

Latest Holdings of R Sanders Williams

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2022-08-22 5,301 267.30 1,416,957
LH Laboratory Corp of America Holdings 2022-03-25 6,431 204.82 1,317,165
BMY Bristol-Myers Squibb Co 2006-09-11 500 48.86 24,430

Holding Weightings of R Sanders Williams


R Sanders Williams Form 4 Trading Tracker

According to the SEC Form 4 filings, R Sanders Williams has made a total of 10 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Amgen Inc is the sale of 200 shares on August 22, 2022, which brought R Sanders Williams around $49,992.

According to the SEC Form 4 filings, R Sanders Williams has made a total of 5 transactions in Laboratory Corp of America Holdings (LH) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Laboratory Corp of America Holdings is the sale of 572 shares on March 25, 2022, which brought R Sanders Williams around $156,145.

According to the SEC Form 4 filings, R Sanders Williams has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 0 shares on September 11, 2006, which brought R Sanders Williams around $0.

Insider Trading History of R Sanders Williams

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

R Sanders Williams Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

R Sanders Williams Ownership Network

Ownership Network List of R Sanders Williams

No Data

Ownership Network Relation of R Sanders Williams


R Sanders Williams Owned Company Details

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

R Sanders Williams is the director of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .

Amgen Inc () Insider Trades Summary

Over the past 18 months, R Sanders Williams made no insider transaction in Amgen Inc (). Other recent insider transactions involving Amgen Inc () include a net sale of 2,641 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 22,586 shares of Amgen Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,586 shares.

Amgen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amgen Inc Insider Transactions

No Available Data

R Sanders Williams Mailing Address

Above is the net worth, insider trading, and ownership report for R Sanders Williams. You might contact R Sanders Williams via mailing address: Duke University School Of Medicine, Trent Drive, Durham Nc 27706.

Discussions on R Sanders Williams

No discussions yet.